Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients. (Q43989451)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

François Guilhot

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Jill Corre

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Michel Attal

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Herve Avet-Loiseau

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

B Hebraud

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

X Leleu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

V Lauwers-Cances

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

D Caillot

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

G Marit

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

L Karlin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

C Hulin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

C Gentil

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

L Garderet

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

T Lamy

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

S Brechignac

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

B Pegourie

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

J Jaubert

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

M Dib

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

A-M Stoppa

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

C Sebban

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

C Fohrer

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

J Fontan

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

C Fruchart

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

M Macro

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

F Orsini-Piocelle

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

G Lepeu

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

C Sohn

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

T Facon

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

P Moreau

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

29 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

675-679

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

International staging system for multiple myeloma

6 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.225

International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.225

Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.225

p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.225

Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.225

Prognostic significance of copy-number alterations in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.225

Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.225

Deletions of CDKN2C in multiple myeloma: biological and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.225

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.225

Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.225

Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.225

Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.225

Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplant

21 January 2018

1 reference

12 December 2020

A note on quantifying follow-up in studies of failure time

1 reference

12 December 2020

A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value

1 reference

12 December 2020

Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy

1 reference

12 December 2020

Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy

1 reference

12 December 2020

Identifiers

DOI

10.1038/LEU.2013.225

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

6 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23892719%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

PubMed publication ID

23892719

1 reference